1 / 21

Duration of Dual Antiplatelet Therapy

Duration of Dual Antiplatelet Therapy. European and US Guidelines. PCI-CURE CV Death or MI. CHARISMA Instantaneous Hazard for Moderate or Severe Bleeding. CHARISMA Primary End Point. TRILOGY-ACS Primary Efficacy End Point to 30 Months (Age < 75 years). DAPT Trial Total Enrollment .

willa
Download Presentation

Duration of Dual Antiplatelet Therapy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Duration of Dual Antiplatelet Therapy

  2. European and US Guidelines

  3. PCI-CURECV Death or MI

  4. CHARISMAInstantaneous Hazard for Moderate or Severe Bleeding

  5. CHARISMA Primary End Point

  6. TRILOGY-ACS Primary Efficacy End Point to 30 Months (Age < 75 years)

  7. DAPT TrialTotal Enrollment

  8. DES vs BMS

  9. DAPT Trials Unanswered Questions

  10. OPTIMIZESecond-generation DESEffect of Short- and Long-term DAPT

  11. New Trials With Ticagrelor

  12. Abbreviations

  13. Abbreviations (cont)

  14. Abbreviations (cont)

  15. References

  16. References (cont)

  17. References (cont)

  18. References (cont)

More Related